---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-005788"
form_type: "8-K"
ticker: "OCEA"
cik: "0001869974"
company_name: "Ocean Biomedical, Inc."
filed_at: "2025-04-23T23:59:59+00:00"
generated_at: "2026-05-23T08:24:15.826065+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Ocean Biomedical receives Nasdaq delisting notice, plans to appeal; expands into energy and crypto

## Summary
- Nasdaq determined OCEA common stock will be delisted and trading suspended effective April 24, 2025.
- Company intends to appeal the delisting determination within 15 days but warns no guarantee of success.
- Director Jake Kurtis resigned immediately on April 22, 2025 to pursue other interests.
- Strategic expansion into power infrastructure and cryptocurrency treasury (Bitcoin and Solana) announced.
- No specific financial commitments, project sizes, or capital sources disclosed for the new sectors.

## SEC filing metadata
- accession: 0001641172-25-005788
- form_type: 8-K
- ticker: OCEA
- cik: 0001869974
- company_name: Ocean Biomedical, Inc.
- filed_at: 2025-04-23T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 3.01, 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1869974/000164117225005788/0001641172-25-005788-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1869974/000164117225005788/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-005788
- JSON: https://secwatch.observer/filing/0001641172-25-005788.json
- Plain text: https://secwatch.observer/filing/0001641172-25-005788.txt

## Key facts
- Listing & Compliance Notices
  Ocean Biomedical, Inc. received a nasdaq delisting notice notice regarding other.
  - Exchange: nasdaq
  - Notice: delisting notice
  source text: April 22, 2025, Ocean Biomedical, Inc. received a letter from Nasdaq determining that OCEA’s common stock will be delisted from Nasdaq and that trading in its securities will be suspended effective upon the open of business on April 24, 2025. The letter also stated that Nasdaq intends to complete delisting by filing a Form 25 Notification of Delisting with the SEC after applicable appeal periods have lapsed. Pursuant to Nasdaq listing rules, the Company has the right to appeal Nasdaq’s delisting determination within 15 days of the date of the letter. The Company intends to file its appeal fort
  evidence_url: https://www.sec.gov/Archives/edgar/data/1869974/000164117225005788/0001641172-25-005788-index.htm
- Executive change
  Jake Kurtis resigned as Director at Ocean Biomedical, Inc..
  - Action: resigned
  - Role: Director
  source text: On April 22, 2025, Jake Kurtis notified the Company of his immediate resignation as a director of the Company to pursue other interests.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1869974/000164117225005788/0001641172-25-005788-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.